VCP ScannerFree US Stock Screener & Financial AnalysisFree US Stock Screener
ScreenerThemes
DCF ValuationCalculate intrinsic value of US stocks
Market ValuationBuffett indicator, CAPE & macro gauges
Total ReturnSee dividends + price return history
DCA CalculatorSimulate recurring buys & compounding
Earnings
FAANG & Tech
AAPL vs MSFTNVDA vs AMDGOOGL vs META
Cloud & Cyber
CRM vs NOWCRWD vs PANWSNOW vs DDOG
Consumer & Auto
TSLA vs FAMZN vs WMTNFLX vs DIS
Finance & Crypto
JPM vs BACV vs MACOIN vs MSTR
Pharma & Energy
LLY vs NVOJNJ vs PFEXOM vs CVX
Compare Any Stocks...
WatchlistInsider
ScreenerThemes
Earnings
WatchlistInsider
AKRO
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Verify deeply. Act with conviction.

Data updated daily

Product

  • Screener
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly stock ideas — free

© 2026 VCP Scanner
AboutPrivacyTerms
Not financial advice. Do your own research.
ScreenerNewsCompareWatchlist
AKROAkero Therapeutics, Inc.
$54.65$4.5B
Overview & Verdict
Overview
Valuation & Forecasts
Valuation ModelsEstimatesDCF Model
Price & Analyst Data
Analyst TargetsPrice HistoryTechnical Analysis
Financial Statements
Income StatementBalance SheetCash FlowRatios & Margins
Performance
P/E HistoryRevenue HistoryEarnings HistoryDividend HistoryTotal Return
Ownership
Holders
HomeStocksAKROQuarterly Financials

Akero Therapeutics, Inc. (AKRO) Quarterly Financials

120+ quarters historyFree accessUpdated daily

Akero Therapeutics, Inc. (AKRO) quarterly income statement — complete revenue, gross profit & net income history

AKRO Income Statement

Income StatementBalance SheetCash FlowRatios
AnnualQuarterly
MetricQ3'25Q2'25Q1'25Q4'24Q3'24Q2'24Q1'24Q4'23Q3'23Q2'23Q1'23Q4'22Q3'22Q2'22Q1'22Q4'21Q3'21Q2'21Q1'21Q4'20
Sales/Revenue00000000000000000000
Revenue Growth %--------------------
Cost of Goods Sold000001K1K0000000000000
COGS % of Revenue--------------------
Gross Profit00000-1K-1K0000000000000
Gross Margin %--------------------
Gross Profit Growth %-100%100%-----------------
Operating Expenses90.24M80.87M80.88M78.03M81.7M65.74M59.95M61.87M46.62M35.63M28.75M25.42M36.09M27.59M26.05M32.44M24.35M28.97M15.13M29.78M
OpEx % of Revenue--------------------
Selling, General & Admin11.35M11.62M11.31M8.73M9.47M10.42M9.3M8.48M7.98M7.64M6.97M7.1M11M6.23M5.54M4.73M4.88M4.99M4.53M4.07M
SG&A % of Revenue--------------------
Research & Development78.88M69.25M69.57M69.29M72.23M55.32M50.65M53.39M38.63M27.98M21.79M18.32M25.09M21.36M20.51M27.71M19.47M23.98M10.6M25.71M
R&D % of Revenue--------------------
Other Operating Expenses00000000000000000000
Operating Income-90.24M-80.87M-80.88M-78.03M-81.7M-65.74M-59.95M-61.87M-46.62M-35.63M-28.75M-25.42M-36.09M-27.59M-26.05M-32.44M-24.35M-28.97M-15.13M-29.78M
Operating Margin %--------------------
Operating Income Growth %-10.44%-23.02%-34.91%-26.11%-75.27%-84.52%-108.51%-143.4%-29.16%-29.12%-10.37%21.64%-48.2%4.74%-72.2%-8.92%-13.07%-76.04%-22.21%-83.61%
EBITDA-90.23M-69.33M-80.88M-78.01M-81.7M-65.74M-59.95M-61.87M-46.61M-35.62M-28.74M-25.41M-36.08M-27.58M-26.04M-32.43M-24.34M-28.96M-15.12M-29.77M
EBITDA Margin %--------------------
EBITDA Growth %-10.44%-5.47%-34.9%-26.08%-75.29%-84.57%-108.59%-143.49%-29.19%-29.13%-10.38%21.64%-48.21%4.74%-72.26%-8.92%-13.06%-91.37%-35.68%-83.54%
D&A (Non-Cash Add-back)4.5K04.5K15K1K1K1K2K5K11K11K10K11K11K11K11K9K10K11K11K
EBIT-80.47M-69.33M-69.57M-68.82M-71.46M-54.76M-52.35M-54.29M-38.77M-30.23M-25.37M-22.7M-35.22M-27.35M-26.03M-32.44M-24.33M-28.93M-15.13M-29.78M
Net Interest Income-1.09M10.37M10.16M8M9M9.75M6.61M6.69M6.96M4.55M2.92M-362K-324K191K22K00038K0
Interest Income011.54M11.31M9.2M10.24M10.98M7.6M7.58M7.84M5.4M3.38M00244K22K00038K0
Interest Expense1.09M1.17M1.15M1.2M1.25M1.23M991K897K888K857K457K362K324K53K000000
Other Income/Expense8.67M10.37M10.16M8M9M9.75M6.61M6.69M6.96M4.55M2.92M2.36M549K191K22K15K23K33K38K72K
Pretax Income-81.57M-70.5M-70.72M-70.02M-72.7M-55.99M-53.34M-55.19M-39.66M-31.08M-25.83M-23.06M-35.54M-27.4M-26.03M-32.42M-24.33M-28.93M-15.09M-29.71M
Pretax Margin %--------------------
Income Tax00000000000000000000
Effective Tax Rate %0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%
Net Income-81.57M-70.5M-70.72M-70.02M-72.7M-55.99M-53.34M-55.19M-39.66M-31.08M-25.83M-23.06M-35.54M-27.4M-26.03M-32.42M-24.33M-28.93M-15.09M-29.71M
Net Margin %--------------------
Net Income Growth %-12.19%-25.93%-32.58%-26.89%-83.33%-80.12%-106.51%-139.33%-11.58%-13.43%0.76%28.88%-46.08%5.29%-72.49%-9.13%-13.68%-78.52%-26.96%-90.32%
Net Income (Continuing)-81.57M-70.5M-70.72M-70.02M-72.7M-55.99M-53.34M-55.19M-39.66M-31.08M-25.83M-23.06M-35.54M-27.4M-26.03M-32.42M-24.33M-28.93M-15.09M-29.71M
Discontinued Operations00000000000000000000
Minority Interest00000000000000000000
EPS (Diluted)-0.99-0.86-0.90-0.99-1.05-0.81-0.90-0.99-0.71-0.60-0.50-0.44-0.91-0.77-0.74-0.93-0.70-0.83-0.43-0.86
EPS Growth %5.71%-6.17%0%0%-47.89%-35%-80%-125%21.98%22.08%32.43%52.69%-30%7.23%-72.09%-8.14%-11.11%-45.61%-2.38%-56.36%
EPS (Basic)-0.99-0.86-0.90-0.99-1.05-0.81-0.90-0.99-0.71-0.60-0.50-0.44-0.91-0.77-0.74-0.93-0.70-0.83-0.43-0.86
Diluted Shares Outstanding82.01M81.72M78.66M70.57M69.44M69.16M59.31M55.72M55.61M51.87M46.94M46.76M38.66M35.38M35.01M34.89M34.86M34.81M34.74M34.68M
Basic Shares Outstanding82.01M81.72M78.66M70.57M69.44M69.16M59.31M55.72M55.61M51.87M46.94M46.76M38.66M35.38M35.01M34.89M34.86M34.81M34.74M34.68M
Dividend Payout Ratio--------------------